Who founded Avita Medical?

Avita Medical was founded by Fiona Wood.

Who are Avita Medical's investors?

Avita Medical's investors include OrbiMed.

How much funding has Avita Medical raised?

Avita Medical has disclosed $29.7M raised across 2 rounds.

Where is Avita Medical headquartered?

Avita Medical is headquartered in Melbourne, US.

Avita Medical

NASDAQ: RCEL

Melbourne, US · 1 known investors

Find your way into Avita Medical

137 people in our graph share verified history with the Avita Medical team — schools, employers, funds. One of them is your warm intro.

Jeff Lawsonunlockedknows Dale A Sander · together at Humacyte (overlapped)

×11knows the team · via Marquette University

RECELL is an FDA-approved autologous skin cell suspension device for treating burns, trauma, and surgical wounds by harvesting a patient's own skin cells and applying them to accelerate healing and reduce the need for large skin grafts. The technology serves hospital systems and wound care clinicians treating severe burn and trauma patients.

Biotech Healthtech Medical Devices

Founders & leadership

Fiona Wood

Dale A Sander inChief Financial Officer2017–2019Dale A Sander served as Chief Financial Officer at six life science and business service companies through private and public phases, overseeing financial strategy, corporate development, M&A, and operations across multiple continents. He has led over 25 public and private equity and debt offerings, including three U.S. and European IPOs, and managed company growth ranging from startups to organizations with 60,000 employees.

Cary Vance inPresident & CEOCary Vance is Executive Chairman and Interim Chief Executive Officer of Avita Medical, an FDA-approved autologous skin cell suspension device company. He brings extensive leadership experience in medical technology, business development, and operational optimization, including Lean/Six Sigma certification.

Investors · 1

OrbiMedreportedNew York · $1M – $75M

Reported raises · per SEC filings

Form D private placements

$29.7M disclosed across 2 rounds · 2018–2019

▶$15.4MraisedNov 2019 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Timothy RooneyExecutive Officer

Offering amount: $15.4M
Amount sold: $15.4M
Finders' fees: $461.2K
First sale: Nov 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$14.4MraisedFeb 2019 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Dale A SanderExecutive Officer

Offering amount: $14.4M
Amount sold: $14.4M
Finders' fees: $1.3M
First sale: Dec 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

AiVita Biomedical28 shared keywordsAIVITA Biomedical is a biotechnology company developing personalized vaccines using an autologous cell therapy platform, including a pan-antigenic cancer vaccine that targets all neoantigens and a multi-pathogen vaccine kit for infectious disease prevention. Its work draws on expertise in stem cell growth and high-purity cell differentiation.

Companies competing with Avita Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

TD Cowen raises Avita Medical stock price target on PermeaDerm data By Investing.cominvesting.com · Aug 2026

BTIG raises Avita Medical stock price target on positive trial data By Investing.comuk.investing.com · Aug 2026

Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%finance.yahoo.com · Aug 2026

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven | INNinvestingnews.com · Aug 2026

Frequently asked questions

What does Avita Medical do?: RECELL is an FDA-approved autologous skin cell suspension device for treating burns, trauma, and surgical wounds by harvesting a patient's own skin cells and applying them to accelerate healing and reduce the need for large skin grafts. The technology serves hospital systems and wound care clinicians treating severe burn and trauma patients.
Who founded Avita Medical?: Avita Medical was founded by Fiona Wood.
Who are Avita Medical's investors?: Avita Medical's investors include OrbiMed.
How much funding has Avita Medical raised?: Avita Medical has disclosed $29.7M raised across 2 rounds.
Where is Avita Medical headquartered?: Avita Medical is headquartered in Melbourne, US.